COVID-19 ORAL ANTIVIRAL MK-4482 (MOLNUPIRAVIR)

DEFINITIVE CONTRACT won by MERCK SHARP & DOHME LLC · work in KENILWORTH, NJ
$2,205,000,834
RecipientMERCK SHARP & DOHME LLC UEI FCFDA78HKKG2
Award IDW911QY21C0031
Award amount$2,205,000,834
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Defense — Department of the Army
NAICS325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
PSC6505
Set-asideUnrestricted
Start dateJun 7, 2021
End dateSep 30, 2023
Place of performanceKENILWORTH, NJ
Record updatedAug 3, 2022

View the official award record

More awards won by MERCK SHARP & DOHME LLC

IGF::OT::IGF
Department of Health and Human Services · $236,307,634 · Sep 28, 2017
ERVEBO PROCUREMENT
Department of Health and Human Services · $156,033,983 · Sep 30, 2024
ADDRESSING THE COVID-19 PANDEMIC: URGENT PRIORITIES
Department of Health and Human Services · $102,299,549 · Mar 1, 2021
BPS - ADVANCE THE DEVELOPMENT OF V920, A VACCINE AGAINST EBOLA VIRUS USING A RECOMBINANT VESICULAR STOMATITIS VIRUS VECTOR. IGF::OT::IGF
Department of Health and Human Services · $65,103,309 · Aug 29, 2016
VACCINE STORAGE AND ROTATION, 2021-2026
Department of Health and Human Services · $6,426,702 · Sep 16, 2021

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids